View of Apixaban Concentration with and without Coadministration of Carbamazepine: A Case with No Apparent Interaction | Canadian Journal of Hospital Pharmacy
![Table 1 from Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical Table 1 from Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical](https://d3i71xaburhd42.cloudfront.net/a95b8fcf4e4c1214a71c3468cd5994af24aea189/3-Table1-1.png)
Table 1 from Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical
![Safety and effectiveness of reduced-dose apixaban in Japanese patients with nonvalvular atrial fibrillation in clinical practice: A sub-analysis of the STANDARD study - ScienceDirect Safety and effectiveness of reduced-dose apixaban in Japanese patients with nonvalvular atrial fibrillation in clinical practice: A sub-analysis of the STANDARD study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0914508719302230-gr1.jpg)
Safety and effectiveness of reduced-dose apixaban in Japanese patients with nonvalvular atrial fibrillation in clinical practice: A sub-analysis of the STANDARD study - ScienceDirect
![Apixaban Concentrations in Routine Clinical Care of Older Adults With Nonvalvular Atrial Fibrillation - ScienceDirect Apixaban Concentrations in Routine Clinical Care of Older Adults With Nonvalvular Atrial Fibrillation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2772963X22000400-fx1.jpg)